Skip to main content

Advertisement

Log in

Long-term clinical course of immunotactoid glomerulopathy complicated with diffuse large B-cell lymphoma

  • Case Report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

We report a case of immunotactoid glomerulopathy (ITG) complicated with diffuse large B-cell lymphoma (DLBCL). A 68-year-old woman presented with leg edema and was diagnosed with nephrotic syndrome (NS). Renal biopsy revealed ITG. We treated the patient with prednisolone (20 mg/day) and she achieved complete remission of NS. Steroids were gradually reduced. After 1 year, the patient presented with a breast mass determined on biopsy to be DLBCL. She underwent six cycles of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) therapy. Follow-up revealed complete remission of both DLBCL and ITG. NS recurred after 5 years and she was simultaneously diagnosed with recurrence of DLBCL in bone marrow. She underwent four cycles of R-EPOCH (rituximab, etoposide, prednisolone, vincristine, cyclophosphamide, doxorubicin) therapy and entered remission for DLBCL. NS improved, but the treatment did not lead to remission. After 2 additional years, NS and DLBCL recurred again. She was administered rituximab and NS improved, although proteinuria tended to increase thereafter. One year later, we started prednisolone (10 mg/day), and proteinuria tended to decrease. She is currently undergoing outpatient follow-up. This case suggests that ITG with MGUS should be treated with the possibility of developing malignant hematological disease during the course.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Rosenmann E, Eliakim M. Nephrotic syndrome associated with amyloid-like glomerular deposits. Nephron. 1997;18:301–8.

    Article  Google Scholar 

  2. Alpers CE. Immunotactoid (microtubular) glomerulopathy: an entity distinct from fibrillary glomerulonephritis? Am J Kidney Dis. 1992;19:185–91.

    Article  CAS  Google Scholar 

  3. Schwartz MM, Lewis EJ. The quarterly case: nephrotic syndrome in a middle-aged man. Ultrastruct Pathol. 1980;1(4):575–82.

    Article  CAS  Google Scholar 

  4. Bridoux X, Hugue V, Coldefy O, Goujon JM, Bauwens M, Sechet A, et al. Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features. Kidney Int. 2002;52:1764–75.

    Article  Google Scholar 

  5. Rosenstock JL, Markowitz GS, Valeri AM, Sacchi G, Appel GB, D’Agati VD. Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features. Kidney Int. 2003;63:1450–61.

    Article  Google Scholar 

  6. Nasr SH, Fildler ME, Cornell LD, Leung N, Cosio FG, Sheikh SS, et al. Immunotactoid glomerulopathy: clinicopathologic and proteomic study. Nephrol Dial Transplant. 2012;27:4137–46.

    Article  CAS  Google Scholar 

  7. Alpers CE, Kowalewska J. Fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol. 2008;19:34–7.

    Article  Google Scholar 

  8. Khandelwal A, Trinkaus MA, Ghaffar H, Jothy S, Goldstein MB. A case report of unusually long lag time between immunotactoid glomerulopathy (itg) diagnosis and diffuse large B-cell lymphoma (DLBCL) development. BMC Nephrol. 2016;17:140.

    Article  Google Scholar 

  9. Castro JE, Diaz-Perez JA, Barajas-Gamboa JS, Horton JM, Weidner N, Kipps TJ. Chronic lymphocytic leukemia associated with immunotactoid glomerulopathy: a case report of successful treatment with high-dose methylprednisolone in combination with rituximab followed by alemtuzumab. Leuk Lymphoma. 2012;53(9):1835–8.

    Article  CAS  Google Scholar 

  10. Jacobson E, Sharp G, Rimmer J, MacPherson B. A 59-year-old-woman with immunotactoid glomerulopathy, heavy-chain disease, and non-Hodgkin lymphoma. Arch Pathol Lab Med. 2004;128(6):689–92.

    Article  Google Scholar 

  11. Korbet SM, Schwartz MM, Rosenberg BF, Sibley RK, Lewis EJ. Immunotactoid glomerulopathy. Medicine. 1985;64:228–43.

    Article  CAS  Google Scholar 

  12. Brady HR. Fibrillary glomerulopathy. Kidney Int. 1998;53:1421–9.

    Article  CAS  Google Scholar 

  13. Schwartz MM, Korbet SM, Lewis EJ. Immunotactoid glomerulopathy. J Am Soc Nephrol. 2002;13:1390–7.

    Article  Google Scholar 

  14. Rood IM, Lieverse LG, Steenbergen EJ, Wetzels JF, Deegens JK. Spontaneous remission of immunotactoid glomerulopathy. Neth J Med. 2011;69(7):341–4.

    CAS  PubMed  Google Scholar 

  15. Moriyama T, Honda K, Tsukada M, Koike M, Itoh K, Nitta K, et al. A case of immunotactoid glomerulopathy with IgA2, kappa deposition ameliorated by steroid therapy. Nihon Jinzo Gakkai Shi. 2003;45(5):449–56.

    PubMed  Google Scholar 

  16. Kinomura M, Maeshim Y, Kodera R, Morinaga H, Saito D, Nakao K, et al. A case of immunotactoid glomerulopathy exhibiting nephrotic syndrome successfully treated with corticosteroids and antihypertensive therapy. Clin Exp Nephrol. 2009;13:378–84.

    Article  Google Scholar 

  17. Ohashi A, Kumagai J, Nagahama K, Fujisawa H. Case of immunotactoid glomerulopathy showing high responsiveness to steroids therapy despite severe pathological features. BMJ Case Rep. 2019;12:e229751.

    Article  Google Scholar 

  18. Kurosu M, Ando Y, Takeda S, Kusano E, Sakurai T, Kuriki K, et al. Immunotactoid glomerulopathy characterized by steroid-responsive massive subendothelial deposition. Am J Kidney Dis. 2001;37(3):E21.

    Article  CAS  Google Scholar 

  19. Kurihara I, Saito T, Sato H, Chiba J, Saito J, Soma J, et al. Successful treatment with steroid pulse therapy in a case of immunotactoid glomerulopathy with hypocomplementemia. Am J Kidney Dis. 1998;32(1):E4.

    Article  CAS  Google Scholar 

  20. Da’as N, Kleinman Y, Polliack A, Amir G, Ne’eman Z, Kopolovic J, et al. Immunotactoid glomerulopathy with massive bone marrow deposits in a patient with IgM kappa monoclonal gammopathy and hypocomplementemia. Am J Kidney Dis. 2001;38:395–9.

    Article  CAS  Google Scholar 

  21. Minami J, Ishimitsu T, Inenaga T, Ishibashi-Ueda H, Kawano Y, Takishita S. Immunotactoid glomerulopathy: report of a case. Am J Kidney Dis. 1997;30:160–3.

    Article  CAS  Google Scholar 

  22. Witzens-Harig M, Waldherr R, Beimler J, Zeier M, Hansmann J, Ho AD, et al. Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation. Ann Hematol. 2007;86:927–30.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Richard Robins, PhD, from Edanz Group (https://en-author-services.edanzgroup.com/ac) for editing a draft of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Haruka Takahashi.

Ethics declarations

Conflict of interest

The authors have declared that no conflict of interest exist.

Research involving human participants and/or animals

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takahashi, H., Sano, T., Kawamura, S. et al. Long-term clinical course of immunotactoid glomerulopathy complicated with diffuse large B-cell lymphoma. CEN Case Rep 11, 184–190 (2022). https://doi.org/10.1007/s13730-021-00648-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-021-00648-0

Keywords

Navigation